Correction: Heart valve prostheses in pregnancy: Outcomes for women and their infants [J Am Heart Assoc., 3, (2014) e000953] DOI: 10.1161/JAHA.114.000953;Heart valve prostheses in pregnancy: Outcomes for women and their infants

Journal of the American Heart Association

Volumn 3, Issue 3, 2014, Pages

  Lawley, Claire M ^a,b   Algert, Charles S ^a   Ford, Jane B ^a   Nippita, Tanya A ^b   Figtree, Gemma A ^b   Roberts, Christine L ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

Cardiovascular diseases; Heart valve prosthesis; Infant; Perinatal mortality; Pregnancy

Indexed keywords

ADULT; ARTICLE; AUSTRALIA; BIOPROSTHESIS; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; FETUS OUTCOME; HEART VALVE PROSTHESIS; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MATERNAL MORBIDITY; MATERNAL MORTALITY; PATIENT CARE; PATIENT COUNSELING; PERINATAL MORBIDITY; PREGNANCY; PREGNANCY OUTCOME; PREMATURE LABOR; PRIORITY JOURNAL; PROGNOSIS; PROSTHETIC VALVE DYSFUNCTION; RISK FACTOR; SMALL FOR DATE INFANT; ABORTION, SPONTANEOUS; ADVERSE EFFECTS; COMPLICATION; GESTATIONAL AGE; HEART VALVE DISEASES; NEW SOUTH WALES; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREVALENCE; STATISTICS AND NUMERICAL DATA;

ABORTION, SPONTANEOUS; ADULT; BIOPROSTHESIS; FEMALE; GESTATIONAL AGE; HEART VALVE DISEASES; HEART VALVE PROSTHESIS; HUMANS; NEW SOUTH WALES; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY OUTCOME; PREVALENCE; RISK FACTORS;

EID: 84937579535     PISSN: None     EISSN: 20479980     Source Type: Journal    
DOI: 10.1161/JAHA.114.000414     Document Type: Erratum

References (49)

1. Fernandes SM, Pearson DD, Rzeszut A, Mitchell SJ, Landzberg MJ, Martin GR; American College of Cardiology ACHDWG, Adult Congenital Cardiac Care Associate Research N. Adult congenital heart disease incidence and consultation: a survey of general adult cardiologists. J Am Coll Cardiol. 2013; 61:1303-1304.
2. Marelli AJ, Mackie AS, Ionescu-Ittu R, Rahme E, Pilote L. Congenital heart disease in the general population: changing prevalence and age distribution. Circulation. 2007;115:163-172.
3. Khairy P, Ionescu-Ittu R, Mackie AS, Abrahamowicz M, Pilote L, Marelli AJ. Changing mortality in congenital heart disease. J Am Coll Cardiol. 2010; 56:1149-1157.
4. Ruel M, Kulik A, Lam BK, Rubens FD, Hendry PJ, Masters RG, Bedard P, Mesana TG. Long-term outcomes of valve replacement with modern prostheses in young adults. Eur J Cardiothorac Surg. 2005;27:425-433; discussion 433.
5. Hui C, Lili M, Libin C, Rui Z, Fang G, Ling G, Jianping Z. Changes in coagulation and hemodynamics during pregnancy: a prospective longitudinal study of 58 cases. Arch Gynecol Obstet. 2012;285:1231-1236.
6. Bremme KA. Haemostatic changes in pregnancy. Baillieres Best Pract Res Clin Haematol. 2003;16:153-168.
7. Gilson GJ, Samaan S, Crawford MH, Qualls CR, Curet LB. Changes in hemodynamics, ventricular remodeling, and ventricular contractility during normal pregnancy: a longitudinal study. Obstet Gynecol. 1997;89:957-962.
8. Abbas AE, Lester SJ, Connolly H. Pregnancy and the cardiovascular system. Int J Cardiol. 2005;98:179-189.
9. Poppas A, Shroff SG, Korcarz CE, Hibbard JU, Berger DS, Lindheimer MD, Lang RM. Serial assessment of the cardiovascular system in normal pregnancy. Role of arterial compliance and pulsatile arterial load. Circulation. 1997;95:2407-2415.
10. Siu SC, Sermer M, Colman JM, Alvarez AN, Mercier LA, Morton BC, Kells CM, Bergin ML, Kiess MC, Marcotte F, Taylor DA, Gordon EP, Spears JC, Tam JW, Amankwah KS, Smallhorn JF, Farine D, Sorensen S; Cardiac Disease in Pregnancy I. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation. 2001;104:515-521.
11. Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O'Gara PT, O'Rourke RA, Otto CM, Shah PM, Shanewise JS; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008;52:23.
12. Basude S, Hein C, Curtis SL, Clark A, Trinder J. Low-molecular-weight heparin or warfarin for anticoagulation in pregnant women with mechanical heart valves: What are the risks? A retrospective observational study BJOG. 2012;119:1008-1013; discussion 1012-1003.
13. Yinon Y, Siu SC, Warshafsky C, Maxwell C, McLeod A, Colman JM, Sermer M, Silversides CK. Use of low molecular weight heparin in pregnant women with mechanical heart valves. Am J Cardiol. 2009;104:1259-1263.
14. Quinn J, Von Klemperer K, Brooks R, Peebles D, Walker F, Cohen H. Use of high intensity adjusted dose low molecular weight heparin in women with mechanical heart valves during pregnancy: a single-center experience. Haematologica. 2009;94:1608-1612.
15. McLintock C. Anticoagulant therapy in pregnant women with mechanical prosthetic heart valves: no easy option. Thromb Res. 2011;127(suppl 3):S56-S60.
16. Castellano JM, Narayan RL, Vaishnava P, Fuster V. Anticoagulation during pregnancy in patients with a prosthetic heart valve [review]. Nat Rev Cardiol. 2012;9:415-424.
17. Chan WS, Anand S, Ginsberg JS. Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature. Arch Intern Med. 2000;160:191-196.
18. Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C, Cifkova R, Ferreira R, Foidart JM, Gibbs JSR, Gohlke-Baerwolf C, Gorenek B, Iung B, Kirby M, Maas AHEM, Morais J, Nihoyannopoulos P, Pieper PG, Presbitero P, Roos-Hesselink JW, Schaufelberger M, Seeland U, Torracca L, Bax J, Auricchio A, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Knuuti J, Kolh P, McDonagh T, Moulin C, Poldermans D, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Torbicki A, Vahanian A, Windecker S, Baumgartner H, Aguiar C, Al-Attar N, Garcia AA, Antoniou A, Coman I, Elkayam U, Gomez-Sanchez MA, Gotcheva N, Hilfiker-Kleiner D, Kiss RG, Kitsiou A, Konings KTS, Lip GYH, Manolis A, Mebaaza A, Mintale I, Morice MC, Mulder BJ, Pasquet A, Price S, Priori SG, Salvador MJ, Shotan A, Silversides CK, Skouby SO, Stein JI, Tornos P, Vejlstrup N, Walker F, Warnes C. ESC guidelines on the management of cardiovascular diseases during pregnancy. Eur Heart J. 2011;32:3147-3197.
19. Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Baron-Esquivias G, Baumgartner H, Borger MA, Carrel TP, De Bonis M, Evangelista A, Falk V, Iung B, Lancellotti P, Pierard L, Price S, Schafers HJ, Schuler G, Stepinska J, Swedberg K, Takkenberg J, Von Oppell UO, Windecker S, Zamorano JL, Zembala M, Bax JJ, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Von Segesser L, Badano LP, Bunc M, Claeys MJ, Drinkovic N, Filippatos G, Habib G, Pieter Kappetein A, Kassab R, Lip GYH, Moat N, Nickenig G, Otto CM, Pepper J, Piazza N, Pieper PG, Rosenhek R, Shuka N, Schwammenthal E, Schwitter J, Mas PT, Trindade PT, Walther T. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J. 2012;33:2451-2496.
20. ABS. Births Australia 2011. 2013.
21. Kelman CW, Bass AJ, Holman CD. Research use of linked health data-a best practice protocol. Aust N Z J Public Health. 2002;26:251-255.
22. Jaro MA. Probabilistic linkage of large public health data files. Stat Med. 1995;14:491-498.
23. Meray N, Reitsma JB, Ravelli AC, Bonsel GJ. Probabilistic record linkage is a valid and transparent tool to combine databases without a patient identification number. J Clin Epidemiol. 2007;60:883-891.
24. Roberts CL, Cameron CA, Bell JC, Algert CS, Morris JM. Measuring maternal morbidity in routinely collected health data: development and validation of a maternal morbidity outcome indicator. Med Care. 2008;46:786-794.
25. Roberts CL, Lancaster PA. Australian national birthweight percentiles by gestational age. Med J Aust. 1999;170:114-118.
26. Roberts CL, Bell JC, Ford JB, Morris JM. Monitoring the quality of maternity care: how well are labour and delivery events reported in population health data? Paediatr Perinat Epidemiol. 2009;23:144-152.
27. Taylor L, Pym M, Bajuk B, Sutton L, Travis S, Banks C. Validation study: NSW midwives data collection 1998. New South Wales Public Health Bulletin Supplementary Series. 2000;11:97-99.
28. Roberts CL, Bell JC, Ford JB, Hadfield RM, Algert CS, Morris JM. The accuracy of reporting of the hypertensive disorders of pregnancy in population health data. Hypertens Pregnancy. 2008;27:285-297.
29. Abildgaard U, Sandset PM, Hammerstrom J, Gjestvang FT, Tveit A. Management of pregnant women with mechanical heart valve prosthesis: thromboprophylaxis with low molecular weight heparin. Thromb Res. 2009;124:262-267.
30. Sillesen M, Hjortdal V, Vejlstrup N, Sorensen K. Pregnancy with prosthetic heart valves-30 years' nationwide experience in Denmark. Eur J Cardiothorac Surg. 2011;40:448-454.
31. Nidorf M, Tofler O, Gibson P, Brooks B. Valvular surgery in Western Australia: a 15-year review. Med J Aust. 1988;148:6-9.
32. Hunt D, Sloman G, Sutton L. The St jude medical valve-the Australian experience. Med J Aust. 1981;2:276-278.
33. El Shaer F, Hassan W, Latroche B, Helaly S, Hegazy H, Shahid M, Mohamed G, Al-Halees Z. Pregnancy has no effect on the rate of structural deterioration of bioprosthetic valves: long-term 18-year follow up results. J Heart Valve Dis. 2005;14:481-485.
34. Avila WS, Rossi EG, Grinberg M, Ramires JAF. Influence of pregnancy after bioprosthetic valve replacement in young women: a prospective five-year study. J Heart Valve Dis. 2002;11:864-869.
35. Jamieson WRE, Miller DC, Atkins CW, Munro AI, Glower DD, Moore KA, Henderson C. Pregnancy and bioprostheses: influence on structural valve deterioration. Ann Thorac Surg. 1995;60:S282-S287.
36. Yun KL, Miller DC, Moore KA, Mitchell RS, Oyer PE, Stinson EB, Robbins RC, Reitz BA, Shumway NE. Durability of the Hancock MO bioprosthesis compared with standard aortic valve bioprostheses. Ann Thorac Surg. 1995;60:S221-S228.
37. Mazibuko B, Ramnarain H, Moodley J. An audit of pregnant women with prosthetic heart valves at a tertiary hospital in South Africa: a five-year experience. Cardiovasc J Afr. 2012;23:216-221.
38. De Santo LS, Romano G, Della Corte A, D'Oria V, Nappi G, Giordano S, Cotrufo M, De Feo M. Mechanical aortic valve replacement in young women planning on pregnancy: maternal and fetal outcomes under low oral anticoagulation, a pilot observational study on a comprehensive pre-operative counseling protocol. J Am Coll Cardiol. 2012;59:1110-1115.
39. Nishida H, Takahara Y, Takeuchi S, Mogi K, Murayama H. Long-term evaluation of bovine pericardial bioprostheses in young women: influence of pregnancy. Jpn J Thorac Cardiovasc Surg. 2005;53:557-561.
40. Sadler L, McCowan L, White H, Stewart A, Bracken M, North R. Pregnancy outcomes and cardiac complications in women with mechanical, bioprosthetic and homograft valves. BJOG. 2000;107:245-253.
41. Sbarouni E, Oakley CM. Outcome of pregnancy in women with valve prostheses. Br Heart J. 1994;71:196-201.
42. Heuvelman HJ, Arabkhani B, Cornette JMJ, Pieper PG, Bogers AJJC, Takkenberg JJM, Roos-Hesselink JW. Pregnancy outcomes in women with aortic valve substitutes. Am J Cardiol. 2013;111:382-387.
43. Tanous D, Siu SC, Mason J, Greutmann M, Wald RM, Parker JD, Sermer M, Colman JM, Silversides CK. B-type natriuretic peptide in pregnant women with heart disease. J Am Coll Cardiol. 2010;56:1247-1253.
44. Steadman CD, Ray S, Ng LL, McCann GP. Natriuretic peptides in common valvular heart disease. J Am Coll Cardiol. 2010;55:234-248.
45. Siu SC, Sermer M, Harrison DA, Grigoriadis E, Liu G, Sorensen S, Smallhorn JF, Farine D, Amankwah KS, Spears JC, Colman JM. Risk and predictors for pregnancy-related complications in women with heart disease. Circulation. 1997;96:2789-2794.
46. Leary PJ, Leary SE, Stout KK, Schwartz SM, Easterling TR. Maternal, perinatal, and postneonatal outcomes in women with chronic heart disease in Washington state. Obstet Gynecol. 2012;120:1283-1290.
47. Lee CN, Wu CC, Lin PY, Hsieh FJ, Chen HY. Pregnancy following cardiac prosthetic valve replacement. Obstet Gynecol. 1994;83:353-356.
48. Pariente G, Sheiner E, Kessous R, Michael S, Shoham-Vardi I. Association between delivery of a small-for-gestational-age neonate and long-term maternal cardiovascular morbidity. Int J Gynecol Obstet. 2013; 123:68-71.
49. Henderson T, Shepheard J, Sundararajan V. Quality of diagnosis and procedure coding in ICD-10 administrative data. Med Care. 2006;44:1011-1019.